The American Medical Association (AMA) today called on public officials and the media to utilize the World Health Organization’s nomenclature for the pandemic - the coronavirus or COVID-19 - and to abstain from using racially charged and xenophobic language that associates the virus with geography or populations of people.
Amid reports of individuals and organizations encouraging use of language like “the Wuhan virus,” “the Chinese coronavirus,” and similar variations, the AMA said in a press release that this language serves no legitimate purpose and is “ethically inappropriate, derogatory and divisive.
“With the world reeling from the health and economic crisis of COVID-19, anti-immigrant and racist rhetoric exacerbates the pandemic, threatening people’s well-being and driving us further apart,” AMA President Patrice A. Harris, M.D., M.A., said in a press release.
President Trump has referred to SARS-CoV-2 as the Chinese virus. The AMA statement came as the he and other officials in his administration put blame of various kinds and degrees on the Chinese government for causing the pandemic.
On call-in show on Fox News Sunday night that was filmed from Lincoln Memorial, the president said the Chinese allowed flights out of Wuhan, where the pandemic started, to other countries but not to other places in China. “You could fly out of Wuhan and you could go to different parts of the world, but you couldn’t go to Beijing [or] any place in China. So what’s that all about?”
A little later Trump added, “They allowed this to go into our country. They allowed it to go into other countries.”
Trump was asked about his statement last he saw evidence that gave him high confidence that the virus came from a Wuhan lab. He responded: “We’re going to be given a very strong report as to exactly what we think happened. And I think it will be very conclusive” Asked whether if there was any suggestion that was anything nefarious or just a mistake, Trump said, “So, personally, I think they made a horrible mistake and they didn’t want to admit it. We wanted to go in. They didn’t want us there. Even World Health [Organization] wanted to go in. They were admitted, but much later.”
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More